LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

LLY

1,014.98

-0.96%↓

JNJ

240.9

+1.12%↑

ABBV

220.69

-0.72%↓

NVS

159.71

+1.01%↑

MRK

119.32

+1.9%↑

Search

ICU Medical Inc

Open

BrancheGesundheitswesen

146.22 0.07

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

144.56

Max

148.74

Schlüsselkennzahlen

By Trading Economics

Einkommen

-39M

-3.4M

Verkäufe

-12M

537M

Gewinnspanne

-0.632

Angestellte

15,000

EBITDA

-40M

67M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+15.24% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

19. Feb. 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

716M

3.7B

Vorheriger Eröffnungskurs

146.15

Vorheriger Schlusskurs

146.22

Nachrichtenstimmung

By Acuity

34%

66%

87 / 352 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Very Strong Bullish Evidence

ICU Medical Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

11. Feb. 2026, 23:47 UTC

Heiße Aktien

Stocks to Watch: AppLovin, Cisco, Cognex, Pilgrim's Pride

11. Feb. 2026, 22:59 UTC

Ergebnisse
Akquisitionen, Fusionen, Übernahmen

Grab Holdings to Buy U.S.-Based Stash Financial

11. Feb. 2026, 23:54 UTC

Ergebnisse

McDonald's Says Its Value Campaign Is Paying Off -- 2nd Update

11. Feb. 2026, 23:50 UTC

Market Talk

Global Equities Roundup: Market Talk

11. Feb. 2026, 23:50 UTC

Market Talk

Nikkei May Rise on Hopes for Takaichi's Economic Steps -- Market Talk

11. Feb. 2026, 23:49 UTC

Ergebnisse

Singtel: Key Focus Areas Are Strengthening Core Businesses, Scaling Growth Engines, Building Momentum Across Regional Associates >Z74.SG

11. Feb. 2026, 23:45 UTC

Ergebnisse

Singtel: Net Exceptional Gain of S$1.15B in 3Q Primarily From Sale of Partial Stake in Bharti Airtel>Z74.SG

11. Feb. 2026, 23:42 UTC

Ergebnisse

Singtel 3Q Underlying Net Profit S$744M Vs. S$680M >Z74.SG

11. Feb. 2026, 23:41 UTC

Ergebnisse

Singtel 3Q Net S$1.89B Vs. Net S$1.32B >Z74.SG

11. Feb. 2026, 23:40 UTC

Ergebnisse

Singtel 3Q Operating Revenue S$3.66B Vs. S$3.63B >Z74.SG

11. Feb. 2026, 23:35 UTC

Market Talk

Gold Falls on Prospects of Long Fed Pause -- Market Talk

11. Feb. 2026, 23:18 UTC

Market Talk

AppLovin CEO Looks to Soothe Concerns Over AI, Competition -- Market Talk

11. Feb. 2026, 23:14 UTC

Market Talk

RBA Governor Faces Barrage of Questions About Govt Spending -- Market Talk

11. Feb. 2026, 22:59 UTC

Ergebnisse

Kakao 2025 Net KRW525.72B Vs. Loss KRW161.87B >035720.SE

11. Feb. 2026, 22:59 UTC

Ergebnisse

Kakao 2025 Oper Pft KRW732.04B Vs. Pft KRW460.21B >035720.SE

11. Feb. 2026, 22:59 UTC

Ergebnisse

Kakao 2025 Rev KRW8.099T Vs. KRW7.872T >035720.SE

11. Feb. 2026, 22:58 UTC

Ergebnisse

Kakao 4Q Net Loss Missed FactSet-Compiled Consensus

11. Feb. 2026, 22:57 UTC

Ergebnisse

Kakao 4Q Loss KRW39.30B Vs. Loss KRW395.21B >035720.SE

11. Feb. 2026, 22:54 UTC

Ergebnisse

Kakao 4Q Oper Pft KRW203.45B Vs. Pft KRW75.43B >035720.SE

11. Feb. 2026, 22:53 UTC

Ergebnisse

Kakao 4Q Rev KRW2.133T Vs. KRW1.957T >035720.SE

11. Feb. 2026, 22:47 UTC

Ergebnisse

AppLovin Reports Strong Earnings. The Stock Is Down. -- Barrons.com

11. Feb. 2026, 22:47 UTC

Ergebnisse

AppLovin Reports Strong Earnings. The Stock Is Down. -- Barrons.com

11. Feb. 2026, 22:23 UTC

Ergebnisse

Grab Holdings Expects to Close Stash Acquisition in 3Q of 2026 >GRAB

11. Feb. 2026, 22:22 UTC

Ergebnisse

Grab Holdings to Acquire U.S. Digital Financial Services Company Stash Financial >GRAB

11. Feb. 2026, 22:22 UTC

Ergebnisse

Grab Holdings Sees FY26 Adj Ebitda $700M to $720M >GRAB

11. Feb. 2026, 22:19 UTC

Ergebnisse

Grab Holdings Sees FY26 Rev $4.04B to $4.10B >GRAB

11. Feb. 2026, 22:18 UTC

Ergebnisse

Grab Holdings 4Q Adj Ebitda $148.0M Vs. $97.0M >GRAB

11. Feb. 2026, 22:18 UTC

Ergebnisse

Grab Holdings 4Q Net $153.0M Vs. Net $11.0M >GRAB

11. Feb. 2026, 22:18 UTC

Ergebnisse

Grab Holdings 4Q Oper Pft $52.0M Vs. $2.0M >GRAB

11. Feb. 2026, 22:16 UTC

Ergebnisse

Grab Holdings 4Q Rev $906.0M Vs. $764.0M >GRAB

Peer-Vergleich

Kursveränderung

ICU Medical Inc Prognose

Kursziel

By TipRanks

15.24% Vorteil

12-Monats-Prognose

Durchschnitt 175 USD  15.24%

Hoch 175 USD

Tief 175 USD

Basierend auf 1 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für ICU Medical Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

1 ratings

1

Buy

0

Halten

0

Sell

Technischer Score

By Trading Central

137.16 / N/AUnterstützung & Widerstand

Kurzfristig

Very Strong Bullish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Strong Bearish Evidence

Stimmung

By Acuity

87 / 352 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über ICU Medical Inc

ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps. The company provides IV therapy and diluents, such as sodium chloride, dextrose, balanced electrolyte solutions, lactated ringer's, ringer's, mannitol, sodium chloride/dextrose, and sterile water; and irrigation solutions comprising sodium chloride and sterile water irrigation, physiologic solutions, ringer's irrigation, acetic acid irrigation, glycine irrigation, sorbitol-mannitol irrigation, flexible containers, and pour bottle options. It offers infusion pumps under the Plum 360 and Plum Duo brands; ambulatory and syringe infusion hardware products; IV mediation safety software, including ICU Medical MedNet, an enterprise-class medication management platform; LifeShield and PharmGuard medication infusion safety software; hemodynamic monitoring products; anesthesia systems and devices, breathing circuits, ventilation, respiratory, and specialty airway products; temperature management solutions; anesthesia/pain management trays and components; and professional services. The company's customers include acute care hospitals, wholesalers, ambulatory clinics, and alternate site facilities, including outpatient clinics, home health care providers, and long-term care facilities. ICU Medical, Inc. was founded in 1984 and is based in San Clemente, California.
help-icon Live chat